APA

Gupta R., Raviglione M. C. & Espinal M. A. (20020730). Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?. : The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Chicago

Gupta R, Raviglione M C and Espinal M A. 20020730. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?. : The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Harvard

Gupta R., Raviglione M. C. and Espinal M. A. (20020730). Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?. : The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

MLA

Gupta R, Raviglione M C and Espinal M A. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?. : The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 20020730.